Results 241 to 250 of about 362,216 (339)

Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE‐HF and PRESERVED‐HF

ESC Heart Failure, EarlyView.
Abstract Aims Sodium–glucose co‐transporter‐2 (SGLT2) inhibitors improve health status and outcomes in the setting of heart failure (HF) across the range of ejection fraction (EF). Baseline kidney disease is common in HF, complicates HF management and is strongly linked to worse health status. This study aimed to assess whether the treatment effects of
Andrew P. Ambrosy, Andrew J. Sauer, Shachi Patel, Sheryl L. Windsor, Barry A. Borlaug, Mansoor Husain, Silvio E. Inzucchi, Dalane W. Kitzman, Darren K. McGuire, Sanjiv J. Shah, Kavita Sharma, Guillermo Umpierrez, Mikhail N. Kosiborod   +12 more
wiley   +1 more source

Autophagy fine-tuning by angiotensin-(1-9) in cultured rat cardiomyocytes. [PDF]

Front Cardiovasc Med
Bustamante M, Quiroga C, Mancilla G, Gomez W, Tapia A, Figueroa R, Mondaca-Ruff D, Oyarzún I, Verdejo HE, Lavandero S, Castro P.   +10 more
europepmc   +1 more source

Renin and angiotensin. A survey of some aspects

, 1966
J. J. Brown, A. F. Lever, D. L. Davies, James I. Robertson   +3 more
openalex   +1 more source

A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19. [PDF]

Adv Respir Med
Li R, Zhang J, Ren L.
europepmc   +1 more source

Vericiguat improves cardiac remodelling and function in rats with doxorubicin‐induced cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Purpose Vericiguat, a soluble guanylate cyclase (sGC) stimulator, has been demonstrated effective in improving prognosis of patients with heart failure with reduced ejection fraction. However, there are limited data concerning the effect of vericiguat in patients with doxorubicin (DOX)‐induced cardiomyopathy (DIC).
Wen Chen, Ying Wu, Wei Li, Meiyan Song, Kaizu Xu, Meifang Wu, Liming Lin   +6 more
wiley   +1 more source

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis. [PDF]

BMC Cancer
Yao Z, Qin D, Cao J, Gao C, Xi P, Li S, Wei R.   +6 more
europepmc   +1 more source

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation

ESC Heart Failure, EarlyView.
Abstract Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm. This study evaluated the effects of up‐titration of HF therapies, consisting of beta‐blockers, angiotensin‐converting‐enzyme inhibitors (ACEis ...
Arietje J.L. Zandijk, Bernadet T. Santema, Friso D.J. Inkelaar, Martje H.L. van der Wal, Janke Warink‐Riemersma, Michiel Rienstra, Adriaan A. Voors   +6 more
wiley   +1 more source

Angiotensin IV does not exert prothrombotic effects in vivo. [PDF]

J Mol Cell Cardiol Plus
Wu Q, Gille C, Maderspacher F, Hildebrand B, Thienel M, Clauss S.   +5 more
europepmc   +1 more source

Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Failure, EarlyView.
Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials.
Ignacio García‐Bolao, Roy S. Gardner, Daniel Gras, Antonio D'Onofrio, George Mark, Devi Nair, Nicolas Lellouche, Miroslav Novak, Ronald Lo, Engwooi Chew, David Wright, Andrew Kaplan, Matteo Bertini, Sara Veraghtert, Michelle M. Harbin, Elizabeth Matznick, Patrick Yong, Kenneth M. Stein   +17 more
wiley   +1 more source

STUDIES ON THE RELATIONS BETWEEN ACTION OF ANGIOTENSIN AND CATECHOLAMINE IN THE MECHANISM OF RENAL HYPERTENSION

, 1965
Tsutomu Sakurai
openalex   +2 more sources